These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 36677925)
21. Novel radioiodinated aurones as probes for SPECT imaging of beta-amyloid plaques in the brain. Maya Y; Ono M; Watanabe H; Haratake M; Saji H; Nakayama M Bioconjug Chem; 2009 Jan; 20(1):95-101. PubMed ID: 19072219 [TBL] [Abstract][Full Text] [Related]
22. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques. Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009 [TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease: spect and pet tracers for beta-amyloid imaging. Valotassiou V; Archimandritis S; Sifakis N; Papatriantafyllou J; Georgoulias P Curr Alzheimer Res; 2010 Sep; 7(6):477-86. PubMed ID: 20455860 [TBL] [Abstract][Full Text] [Related]
24. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. Qu W; Kung MP; Hou C; Benedum TE; Kung HF J Med Chem; 2007 May; 50(9):2157-65. PubMed ID: 17411026 [TBL] [Abstract][Full Text] [Related]
25. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease. Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502 [TBL] [Abstract][Full Text] [Related]
27. Optimization of solid-phase extraction (SPE) in the preparation of [ Yao X; Zha Z; Zhao R; Choi SR; Ploessl K; Liu F; Zhu L; Kung HF Nucl Med Biol; 2019 Apr; 71():54-64. PubMed ID: 31152974 [TBL] [Abstract][Full Text] [Related]
28. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains. Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524 [TBL] [Abstract][Full Text] [Related]
29. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930 [TBL] [Abstract][Full Text] [Related]
30. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759 [TBL] [Abstract][Full Text] [Related]
31. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432 [TBL] [Abstract][Full Text] [Related]
32. Antibody engagement with amyloid-beta does not inhibit [ Xiong M; Dahlén A; Roshanbin S; Wik E; Aguilar X; Eriksson J; Sehlin D; Syvänen S J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627 [TBL] [Abstract][Full Text] [Related]
33. Preclinical and clinical study on [ Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345 [TBL] [Abstract][Full Text] [Related]
34. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138 [TBL] [Abstract][Full Text] [Related]
35. [Amyloid-plaque imaging of the brain using PET]. Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182 [TBL] [Abstract][Full Text] [Related]
36. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition. Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653 [TBL] [Abstract][Full Text] [Related]
37. Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer's Disease Brain by Autoradiography Using [ Mondal R; Sandhu YK; Kamalia VM; Delaney BA; Syed AU; Nguyen GAH; Moran TR; Limpengco RR; Liang C; Mukherjee J Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189652 [TBL] [Abstract][Full Text] [Related]
39. IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Zhuang ZP; Kung MP; Hou C; Plössl K; Skovronsky D; Gur TL; Trojanowski JQ; Lee VM; Kung HF Nucl Med Biol; 2001 Nov; 28(8):887-94. PubMed ID: 11711307 [TBL] [Abstract][Full Text] [Related]